PMC8292593_01
LDL Cholesterol levels between 2008 and 2020 and concomitant lipid lowering treatments. Atorva, atorvastatin; Rosu, rosuvastatin; Q2W, every 2 weeks.
fmed-08-699477-g0001.jpg
PMC8292593_01_fmed-08-699477-g0001.jpg
F1
This treatment however failed to effectively reduce LDLc levels that ranged between 5.9 and 6.6 mmol/L for the ensuing 4-years (Figure 1). At 24 months, LDLc was 82% lower as compared to baseline values (from 6.6 to 1.2 mmol/L; Figure 1).